Given the ctDNA findings, Human Epidermal Growth Factor Receptor (HER2) expression by immunohistochemistry (IHC) and ERBB2 amplification by next-generation sequencing on the FFPE biopsy material utilizing a somatic tumor panel (Trusight Oncology 500) were also performed. The gene discussed is ERBB2; the disease is neoplasm.